Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jul;50(7):2928-2943.
doi: 10.1007/s00261-024-04749-z. Epub 2024 Dec 23.

Beyond cholangiocarcinoma: imaging features of mimicking pathologies in the biliary tract

Affiliations
Review

Beyond cholangiocarcinoma: imaging features of mimicking pathologies in the biliary tract

Hala Khasawneh et al. Abdom Radiol (NY). 2025 Jul.

Abstract

Cholangiocarcinoma (CCA) is the second most common primary malignancy of the hepatobiliary system and presents as a heterogeneous disease with three distinct morphological subtypes: mass-forming, periductal-infiltrating, and intraductal-growing, each characterized by distinguishing imaging features. Accurate diagnosis of CCA is challenging due to the overlap of imaging findings with a broad range of benign and malignant conditions. Therefore, it is essential for radiologists to recognize these mimickers and offer a reasonable differential diagnosis, as this has a significant impact on patient management. Although histopathological confirmation is often required for a definitive diagnosis, understanding specific imaging characteristics that differentiate CCA from its mimickers is crucial. This article highlights a variety of benign and malignant conditions that resemble CCA on imaging, emphasizing features that enhance diagnostic accuracy in clinical practice.

Keywords: Cholangiocarcinoma; Differential diagnosis of Cholangiocarcinoma; Radiologic mimickers.

PubMed Disclaimer

Conflict of interest statement

Declarations. Conflict of interest: The authors declare no competing interests.

References

    1. Khan SA, Tavolari S, Brandi G. Cholangiocarcinoma: Epidemiology and risk factors. Liver Int 2019;39 Suppl 1:19-31. https://doi.org/10.1111/liv.14095 - DOI - PubMed
    1. Patel T. Cholangiocarcinoma. Nat Clin Pract Gastroenterol Hepatol 2006;3(1):33-42. https://doi.org/10.1038/ncpgasthep0389 - DOI
    1. Menias CO, Surabhi VR, Prasad SR, Wang HL, Narra VR, Chintapalli KN. Mimics of cholangiocarcinoma: spectrum of disease. Radiographics 2008;28(4):1115-1129. https://doi.org/10.1148/rg.284075148 - DOI - PubMed
    1. Chiow SM, Khoo HW, Low JK, Tan CH, Low HM. Imaging mimickers of cholangiocarcinoma: a pictorial review. Abdom Radiol (NY) 2022;47(3):981-997. https://doi.org/10.1007/s00261-021-03399-9 - DOI - PubMed
    1. Vilgrain V, Boulos L, Vullierme MP, Denys A, Terris B, Menu Y. Imaging of atypical hemangiomas of the liver with pathologic correlation. Radiographics 2000;20(2):379-397. https://doi.org/10.1148/radiographics.20.2.g00mc01379 - DOI - PubMed

MeSH terms

LinkOut - more resources